🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, Phase III, multicenter, open-label study designed to evalu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-08-27
Trial ID
NCT03991403
Treatments Being Tested
This is a Phase III, global, double-blind, 2-arm randomized study designed ...
Status
Completed
Location
St. Joseph'S Hospital & Medical Center
Start Date
2017-03-08
Trial ID
NCT03038100
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This open-label, Phase Ib study that has six treatment arms is designed to ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2012-07-11
Trial ID
NCT01633970
This is a non-randomized, open-label, dose-escalation, and dose-expansion P...
Status
Active Not Recruiting
Location
Cancer Hospital of Shandong First Medical University
Start Date
2025-03-13
Trial ID
NCT06771622
This study will evaluate the efficacy and safety of atezolizumab when given...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2020-04-09
Trial ID
NCT04194203
Treatments Being Tested
ETOP 15-19 ABC-lung is an international, multi-centre open-label, randomize...
Status
Completed
Location
LungenClinic Grosshansdorf
Start Date
2020-09-29
Trial ID
NCT04245085
Treatments Being Tested
The study will integrate the efficacy of combining the anti programmed deat...
Status
Completed
Location
Willis Knighton Cancer Center
Start Date
2018-09-25
Trial ID
NCT03556839
Treatments Being Tested
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
The main purpose of this study is to validate a safe dose of atezolizumab w...
Status
Completed
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2018-06-19
Trial ID
NCT03394885
Treatments Being Tested